Adjuvant therapy of breast cancer.
This article examines questions about adjuvant systemic therapy, especially in premenopausal and postmenopausal women. The impact of adjuvant therapy on quality of life is addressed, as is the role of doxorubicin in adjuvant chemotherapy. The value of high dose adjuvant chemotherapy and late effects of adjuvant therapy are also examined.
Shapiro
C L
CL
Breast Evaluation Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
Henderson
I C
IC
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D011788:Quality of Life
D000970:Antineoplastic Agents